Congress 115 - HR 5997 - Ensuring Patient Access to Critical Breakthrough Products Act of 2018

Sponsor

Cosponsors

Topics

Administrative remedies Department of Health and Human Services Drug safety, medical device, and laboratory regulation Government studies and investigations Health Health information and medical records Health technology, devices, supplies Home and outpatient care Hospital care Medicare

Full Text

View Full Bill Text

Votes

Summary

Ensuring Patient Access to Critical Breakthrough Products Act of 2018

This bill (1) allows designated medical breakthrough devices to be temporarily covered under Medicare during a specified transitional period, (2) establishes a process to allow for continued coverage after the transitional period has expired, and (3) modifies other Medicare payment systems relating to new medical technology.

Actions

Jun 8, 2018

Referred to the Subcommittee on Health.
Jun 5, 2018

Referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Jun 5, 2018

Introduced in House

Amendments

Related Bills